Frazier Life Sciences Management’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Frazier Life Sciences Management’s Portfolio FLACU Stock Details FLACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,501,000	Closed	-$15.2M	–	50
2022 Q3	$15.2M	Hold	1,501,000	–	–	1.17%	20
2022 Q2	$14.8M	Hold	1,501,000	–	–	1.4%	20
2022 Q1	$15M	Buy	+1,501,000	New	+$14.9M	1.28%	27

Frazier Life Sciences Management's FLACU Position: Q4 2022 in Review

Frazier Life Sciences Management sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q4 2022, closing a stake of 1,501,000 shares — an estimated $15.2M sold.

Frazier Life Sciences Management first reported a position in FLACU in Q1 2022 and held it in 3 quarters. The position peaked at $15.2M in Q3 2022. 0 funds tracked by Wall St. Rank hold FLACU as of Q4 2022.

Frazier Life Sciences Management reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q4 2022 after selling out during the quarter.
Frazier Life Sciences Management sold 1,501,000 Frazier Lifesciences Acquisition Corporation Unit shares in Q4 2022, an estimated $15.2M.
Frazier Life Sciences Management first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q1 2022 and held it in 3 quarters.
Frazier Life Sciences Management's Frazier Lifesciences Acquisition Corporation Unit position peaked at $15.2M in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q4 2022.

Based on Frazier Life Sciences Management's 13F filing for Q4 2022, filed 3 Feb 2023.